Entry |
|
Symbol |
Mapk14, CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15, p38, p38-alpha, p38MAPK, p38a, p38alpha
|
Name |
(RefSeq) mitogen-activated protein kinase 14
|
KO |
|
Organism |
mmu Mus musculus (house mouse)
|
Pathway |
mmu04261 | Adrenergic signaling in cardiomyocytes |
mmu04550 | Signaling pathways regulating pluripotency of stem cells |
mmu04613 | Neutrophil extracellular trap formation |
mmu04620 | Toll-like receptor signaling pathway |
mmu04621 | NOD-like receptor signaling pathway |
mmu04622 | RIG-I-like receptor signaling pathway |
mmu04625 | C-type lectin receptor signaling pathway |
mmu04658 | Th1 and Th2 cell differentiation |
mmu04660 | T cell receptor signaling pathway |
mmu04664 | Fc epsilon RI signaling pathway |
mmu04670 | Leukocyte transendothelial migration |
mmu04723 | Retrograde endocannabinoid signaling |
mmu04750 | Inflammatory mediator regulation of TRP channels |
mmu04914 | Progesterone-mediated oocyte maturation |
mmu04932 | Non-alcoholic fatty liver disease |
mmu04933 | AGE-RAGE signaling pathway in diabetic complications |
mmu04935 | Growth hormone synthesis, secretion and action |
mmu05022 | Pathways of neurodegeneration - multiple diseases |
mmu05163 | Human cytomegalovirus infection |
mmu05167 | Kaposi sarcoma-associated herpesvirus infection |
mmu05170 | Human immunodeficiency virus 1 infection |
mmu05208 | Chemical carcinogenesis - reactive oxygen species |
mmu05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
mmu05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:mmu00001]
09130 Environmental Information Processing
09132 Signal transduction
04015 Rap1 signaling pathway
26416 (Mapk14)
04668 TNF signaling pathway
26416 (Mapk14)
04068 FoxO signaling pathway
26416 (Mapk14)
04071 Sphingolipid signaling pathway
26416 (Mapk14)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
26416 (Mapk14)
09144 Cellular community - eukaryotes
04550 Signaling pathways regulating pluripotency of stem cells
26416 (Mapk14)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
26416 (Mapk14)
04613 Neutrophil extracellular trap formation
26416 (Mapk14)
04620 Toll-like receptor signaling pathway
26416 (Mapk14)
04660 T cell receptor signaling pathway
26416 (Mapk14)
04658 Th1 and Th2 cell differentiation
26416 (Mapk14)
04659 Th17 cell differentiation
26416 (Mapk14)
04657 IL-17 signaling pathway
26416 (Mapk14)
04664 Fc epsilon RI signaling pathway
26416 (Mapk14)
04670 Leukocyte transendothelial migration
26416 (Mapk14)
09152 Endocrine system
04917 Prolactin signaling pathway
26416 (Mapk14)
04926 Relaxin signaling pathway
26416 (Mapk14)
04935 Growth hormone synthesis, secretion and action
26416 (Mapk14)
09156 Nervous system
04728 Dopaminergic synapse
26416 (Mapk14)
04723 Retrograde endocannabinoid signaling
26416 (Mapk14)
04722 Neurotrophin signaling pathway
26416 (Mapk14)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
26416 (Mapk14)
09158 Development and regeneration
04380 Osteoclast differentiation
26416 (Mapk14)
09159 Environmental adaptation
04714 Thermogenesis
26416 (Mapk14)
09160 Human Diseases
09161 Cancer: overview
05205 Proteoglycans in cancer
26416 (Mapk14)
05208 Chemical carcinogenesis - reactive oxygen species
26416 (Mapk14)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
26416 (Mapk14)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
26416 (Mapk14)
05161 Hepatitis B
26416 (Mapk14)
05171 Coronavirus disease - COVID-19
26416 (Mapk14)
05163 Human cytomegalovirus infection
26416 (Mapk14)
05167 Kaposi sarcoma-associated herpesvirus infection
26416 (Mapk14)
05169 Epstein-Barr virus infection
26416 (Mapk14)
09171 Infectious disease: bacterial
05135 Yersinia infection
26416 (Mapk14)
05133 Pertussis
26416 (Mapk14)
05152 Tuberculosis
26416 (Mapk14)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
26416 (Mapk14)
05140 Leishmaniasis
26416 (Mapk14)
05142 Chagas disease
26416 (Mapk14)
09164 Neurodegenerative disease
05014 Amyotrophic lateral sclerosis
26416 (Mapk14)
05020 Prion disease
26416 (Mapk14)
05022 Pathways of neurodegeneration - multiple diseases
26416 (Mapk14)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
26416 (Mapk14)
05418 Fluid shear stress and atherosclerosis
26416 (Mapk14)
05415 Diabetic cardiomyopathy
26416 (Mapk14)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
26416 (Mapk14)
04932 Non-alcoholic fatty liver disease
26416 (Mapk14)
04933 AGE-RAGE signaling pathway in diabetic complications
26416 (Mapk14)
09176 Drug resistance: antineoplastic
01522 Endocrine resistance
26416 (Mapk14)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:mmu01001]
26416 (Mapk14)
Enzymes [BR:mmu01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
26416 (Mapk14)
Protein kinases [BR:mmu01001]
Serine/threonine kinases: CMGC group
MAPK family [OT]
26416 (Mapk14)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
LinkDB |
|
Position |
17:28910316..28967379
|
AA seq |
360 aa
MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ
SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ
KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT
GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTG
TPPAYLINRMPSHEARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA
QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES |
NT seq |
1083 nt +upstreamnt +downstreamnt
atgtcgcaggagaggcccacgttctaccggcaggagctgaacaagaccatctgggaggtg
cccgaacgataccagaacctgtccccggtgggctcgggcgcctatggctcggtgtgtgct
gcttttgatacaaagacggggcatcgtgtggcagttaagaagctgtcgagaccgtttcag
tccatcattcacgccaaaaggacctaccgagagttgcgtctgctgaagcacatgaaacac
gaaaatgtgattggtctgttggatgtgttcacacccgcaaggtcactggaggaattcaat
gacgtgtacctggtgacccatctcatgggggcggacctgaacaacatcgtgaagtgccag
aagctgaccgacgaccacgttcagtttctcatctaccagatcctccgagggctgaagtat
atacattcggctgacataattcacagggacctaaagcccagcaacctagctgtgaacgaa
gactgtgagctcaagattctggattttgggctggctcggcacactgatgatgagatgaca
ggctacgtggctaccaggtggtaccgagccccagagatcatgctgaattggatgcactat
aaccagacagtggatatttggtccgtgggctgcatcatggctgagctgttgaccggaaga
acgttgtttcctggtacagaccatattaaccagcttcagcagataatgcgtctgacgggg
acaccccctgcttatctcattaacaggatgccaagccatgaggcaagaaactacattcag
tctctggcccagatgccgaagatgaacttcgcaaatgtatttattggtgccaatcccctg
gctgtcgacctactggagaagatgctcgttttggactcagataagaggatcacagcagcc
caagctcttgcgcatgcctactttgctcagtaccacgaccctgatgatgagcctgttgct
gacccttatgaccagtcctttgaaagcagggaccttctcatagatgagtggaagagcctg
acctatgatgaagtcatcagctttgtgccaccaccccttgaccaagaagaaatggagtcc
tga |